Search For

Advancing immunotherapy for intrahepatic cholangiocarcinoma: exploring the tumor immune microenvironment and innovative treatments

The role of immune checkpoint inhibitors and/or Yttrium-90 radioembolization in the management of hepatocellular carcinoma: challenges of treatment sequence

Emerging data on immune checkpoint inhibitors in the neoadjuvant and adjuvant setting for patients with hepatocellular carcinoma

Shedding light on the role of LAG-3 in hepatocellular carcinoma: unraveling immunomodulatory pathways

Reflections and perspectives on adjuvant treatment in the setting of resected hepatocellular carcinoma

Challenges and opportunities for treating intrahepatic cholangiocarcinoma: targeted therapy

Signaling and molecular networks related to development and inflammation involved in CCA initiation and progression

The role of tumor microenvironment in cholangiocarcinoma

Targeting the interactions between lymphocytes and liver cancer stem cells in combination with immunotherapy is a promising therapeutic strategy

Immunotherapy biomarkers for HCC: contemporary challenges and emerging opportunities

Tumor microenvironment and immunology of cholangiocarcinoma

Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant